Form 4: HealthStream CTO Reports Routine Stock Transactions

HealthStream's Chief Technology Officer, Jeff Cunningham, reported the acquisition of shares from RSU vesting and the sale of shares for tax obligations.

Summary

• Jeff Cunningham, Chief Technology Officer of HealthStream Inc. (HSTM), reported transactions on March 30, 2026.
• Acquired 5,601 shares of common stock through the vesting of restricted share units (RSUs).
• Disposed of 1,364 shares of common stock at $21.25 per share to cover tax liabilities.
• Following these transactions, Cunningham beneficially owns 37,513 shares of common stock.
• Several tranches of Restricted Share Units (RSUs) vested, converting into common stock, with some vesting contingent on both continued service and achievement of performance criteria.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a routine insider transaction reflecting the vesting of equity compensation and tax-related sales, which is generally neutral but indicates continued executive engagement and performance achievement for specific RSU tranches.

Positives

• Vesting of 5,601 shares of common stock from restricted share units (RSUs) indicates continued employment and fulfillment of vesting conditions.
• Achievement of performance criteria for a tranche of RSUs for the period January 1, 2025, through December 31, 2025, resulted in 20% vesting on March 23, 2026, demonstrating successful operational execution.

Negatives

• Disposal of 1,364 shares of common stock at $21.25 per share to cover tax liabilities, which reduces the reporting person's direct ownership.

Future Outlook

This Form 4 filing does not contain specific forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

StockSavvy.ai notes that insider transactions, such as those reported in a Form 4, provide transparency into executive compensation and ownership changes, which can be a factor in investor sentiment. These transactions are routine for executives receiving equity compensation and typically do not reflect a change in the company's operational or strategic trajectory.

Stakeholder Impact

• Shareholders: The vesting and subsequent sale of shares for tax purposes represent a routine aspect of executive compensation, leading to a minor, expected change in insider ownership. It also signals continued executive alignment with company performance through equity holdings.
• Employees: Reflects standard executive compensation practices involving equity awards, which can be a component of broader employee incentive programs.

Next Steps

• March 19, 2027: 20% vesting of certain service-based RSUs.
• March 20, 2027: 30% vesting of certain service-based RSUs.
• March 22, 2027: 35% vesting of certain service-based RSUs.
• March 23, 2027: 25% vesting of certain performance-based RSUs for the period January 1, 2026, through December 31, 2026.
• March 19, 2028: 30% vesting of certain service-based RSUs.
• March 20, 2028: 35% vesting of certain service-based RSUs.
• March 19, 2029: 35% vesting of certain service-based RSUs.

Key Dates

Recommendation

This Form 4 details routine insider transactions related to executive compensation, specifically the vesting of restricted share units and subsequent tax-related sales. Such transactions are common and do not typically indicate a change in the company's fundamental prospects or warrant a shift in investment recommendation based solely on this filing.

Keywords

HealthStream, HSTM, Form 4, insider trading, stock transaction, RSU, restricted stock units, executive compensation, Jeff Cunningham, Chief Technology Officer